desmethylsertraline has been researched along with Coronary Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cooper, TB; Glassman, AH; Krishnan, KR; Lekht, V; Malinin, AI; O'Connor, CM; Serebruany, VL; Suckow, RF; van Zyl, LT | 1 |
| Gurbel, PA; O'Connor, CM; Serebruany, VL | 1 |
2 other study(ies) available for desmethylsertraline and Coronary Disease
| Article | Year |
|---|---|
Relationship between release of platelet/endothelial biomarkers and plasma levels of sertraline and N-desmethylsertraline in acute coronary syndrome patients receiving SSRI treatment for depression.
Topics: Biomarkers; Blood Platelets; Coronary Disease; Coronary Vessels; Endothelium, Vascular; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline | 2005 |
Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors.
Topics: Coronary Disease; Depression; Flow Cytometry; Humans; In Vitro Techniques; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Receptors, Cell Surface; Selective Serotonin Reuptake Inhibitors; Sertraline | 2001 |